Rhenman & Partners Asset Management’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58M Sell
360,000
-100,000
-22% -$895K 0.44% 66
2025
Q4
$3.89M Hold
460,000
0.36% 70
2025
Q3
$2.4M Hold
460,000
0.27% 80
2025
Q2
$1.59M Hold
460,000
0.2% 77
2025
Q1
$1.21M Hold
460,000
0.14% 84
2024
Q4
$1.9M Hold
460,000
0.19% 82
2024
Q3
$3.26M Buy
460,000
+230,000
+100% +$1.72M 0.26% 77
2024
Q2
$1.5M Hold
230,000
0.14% 81
2024
Q1
$1.91M Sell
230,000
-160,000
-41% -$1.56M 0.18% 76
2023
Q4
$4.29M Buy
390,000
+200,000
+105% +$1.69M 0.43% 61
2023
Q3
$1.6M Hold
190,000
0.17% 76
2023
Q2
$2.39M Hold
190,000
0.25% 71
2023
Q1
$3.02M Sell
190,000
-10,000
-5% -$179K 0.33% 69
2022
Q4
$2.99M Buy
+200,000
New +$3.83M 0.31% 73

Other funds holding RLAY